Clinical Trial Update: A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease [Phase 1, Phase 2]

View source ↗

Summary

A multicenter Phase 1/2 study is evaluating the safety, tolerability, and clinical responses of DSP-1083 in people with Parkinson's disease; recruitment is ongo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• DSP-1083

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Parkinson's Disease | Phase 1, Phase 2 | Status: RECRUITING